Cyclin-dependent kinases 4 and 6 inhibitors (CDK4/6i) versus chemotherapy in luminal B early breast cancer: lessons from the CORALLEEN trial.

Auteurs : de Angelis C, Ignatiadis M, Piccart-Gebhart M
Jaar : 2020
Journal : Ann Transl Med
Volume : 8
Pagina's : 1338